GlobalData on MSN1d
USPTO grants patent to Vistagen’s neuropathic pain treatment
The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...
JD Supra2d
UPC Court of Appeal confirms strict approach to correcting patent errors by interpretation
Alexion Pharmaceuticals v Amgen (UPC_Coa-405/2024) and Alexion Pharmaceuticals v Samsung Bioepis NL BV (UPC_CoA-402/2024); December 20, 2024.
Annual Anaqua Analysis of USPTO Data Finds Strong Increase in Patent Grant Activity
AI patent grants grew in overall volume for the fourth year – increasing from 34,544 in 2020 to 54,022 in 2024 – with innovations in biological-related AI, machine learning AI, image or voice ...
Aprea Therapeutics provides update on existing patent portfolio
Aprea Therapeutics (APRE) provided an update on its existing patent portfolio. Aprea’s ATR inhibitor program is protected by ...
IPWatchdog4d
Bad Patents, Thwarted Patent Reform, and a Failure to Adapt
This week we speak with Scott McKeown, who is a shareholder at Wolf Greenfield and one of the leading U.S. PTAB practitioners ...
No more rubber stamps: best practices for drafting revival petitions for patents and patent applications
Adam Fowles, Dirk Bernhardt and Brett Bostrom of Haynes Boone discuss preparing a revival petition for patents or ...
Vistagen granted USPTO patent for AV-101 to treat neuropathic pain
Vistagen (VTGN) announced that the U.S. Patent and Trademark Office or USPTO, granted a patent to the company for its oral non-opioid product ...
Morningstar8d
Annual Anaqua Analysis of USPTO Data Finds Strong Increase in Patent Grant Activity
With 10,427 granted patents, Samsung Electronics continues to lead the most innovative companies list, with growth areas including multi-device organic light emitting solid state devices ...